Aelis Farma Financials
| AELIS Stock | 2.08 0.12 5.45% |
Aelis |
Understanding current and past Aelis Farma Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Aelis Farma's financial statements are interrelated, with each one affecting the others. For example, an increase in Aelis Farma's assets may result in an increase in income on the income statement.
| Instrument | France Stock View All |
| Exchange | Euronext Paris |
| ISIN | FR0014007ZB4 |
| Business Address | 146 rue Lo |
| Sector | Healthcare |
| Industry | Biotechnology |
| Benchmark | Dow Jones Industrial |
| Website | www.aelisfarma.com |
| Phone | 33 5 57 57 37 70 |
You should never invest in Aelis Farma without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Aelis Stock, because this is throwing your money away. Analyzing the key information contained in Aelis Farma's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Aelis Farma Key Financial Ratios
Aelis Farma's financial ratios allow both analysts and investors to convert raw data from Aelis Farma's financial statements into concise, actionable information that can be used to evaluate the performance of Aelis Farma over time and compare it to other companies across industries.Aelis Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Aelis Farma's current stock value. Our valuation model uses many indicators to compare Aelis Farma value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Aelis Farma competition to find correlations between indicators driving Aelis Farma's intrinsic value. More Info.Aelis Farma SA is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Aelis Farma's earnings, one of the primary drivers of an investment's value.Aelis Farma SA Systematic Risk
Aelis Farma's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Aelis Farma volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Beta measures systematic risk based on how returns on Aelis Farma SA correlated with the market. If Beta is less than 0 Aelis Farma generally moves in the opposite direction as compared to the market. If Aelis Farma Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Aelis Farma SA is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Aelis Farma is generally in the same direction as the market. If Beta > 1 Aelis Farma moves generally in the same direction as, but more than the movement of the benchmark.
Aelis Farma December 16, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Aelis Farma help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Aelis Farma SA. We use our internally-developed statistical techniques to arrive at the intrinsic value of Aelis Farma SA based on widely used predictive technical indicators. In general, we focus on analyzing Aelis Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Aelis Farma's daily price indicators and compare them against related drivers.
| Information Ratio | (0.34) | |||
| Maximum Drawdown | 18.22 | |||
| Value At Risk | (7.23) | |||
| Potential Upside | 3.33 |
Additional Tools for Aelis Stock Analysis
When running Aelis Farma's price analysis, check to measure Aelis Farma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aelis Farma is operating at the current time. Most of Aelis Farma's value examination focuses on studying past and present price action to predict the probability of Aelis Farma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aelis Farma's price. Additionally, you may evaluate how the addition of Aelis Farma to your portfolios can decrease your overall portfolio volatility.